Aaron S.
Project Management | Research & Development | Biotechnology | Pharmaceuticals
Aaron is a proven biologics leader adept at managing teams to discover and develop novel first-in-class antibody therapeutics. Prior to Twist Bioscience, he served as Chief Scientific Officer of LakeP...see more
- Biotechnology & Life Sciences
- Pharmaceutical
€400
/hr
- Pre-vetted expert
- Confirmed hourly rate
- Available on short notice
Experience
Chief Scientific Officer
Twist Bioscience2 years
Current position
Sep 2020 - PresentBuilding a robust antibody discovery engine, leveraging our core competency in DNA synthesis and synthetic library generation, for antibody lead discovery and optimization. Providing e...see more
Chief Scientific Officer, Biopharma & VP, Protein Engineering
Twist Bioscience2 years
May 2018 - Sep 2020
Building a robust antibody discovery engine, leveraging our core competency in DNA synthesis and synthetic library generation, for antibody lead discovery and optimization. Providing e...see more
Chief Scientific Officer
LakePharma, Inc.1 year
Dec 2016 - May 2018
Head of the LakePharma Antibody Center (50+ Scientists) focused on the discovery and development of therapeutic antibodies from both hybridoma and phage display platforms. The Antibody...see more
Vice President of Protein Sciences
Surrozen7 months
May 2016 - Dec 2016
Surrozen is a newly launched biopharmaceutical company founded by world-leading scientists from Stanford University, Drs. Chris Garcia, Roel Nusse, and Calvin Kuo. The company is focuse...see more
Vice President of Research
Sutro Biopharma, Inc.4 years
Jun 2012 - May 2016
Oversee all research functions (Antibody/Protein Engineering, Protein Biochemistry, Informatics, Chemistry) – 30+ Scientists Utilized Sutro's proprietary cell free protein synthesis tec...see more
Senior Director of Antibody Engineering
OncoMed Pharmaceuticals6 years
Jun 2006 - Jun 2012
Responsible for all human antibody lead discovery, engineering, and technology development Discovered tarextumab (Anti-Notch2/3, OMP-59R5, Phase 2), vantictumab (Anti-Fzd7, OMP-18R5, Ph...see more
Senior Director of Lead Discovery
Dyax7 years
Apr 1999 - Jun 2006
Directed Lead Discovery team of 20+ Scientists (Selection/Screening and Molecular Biology): Selection/Screening: Use of antibody/peptide/protein phage display libraries to find therapeu...see more
Industries, roles and expertise
Industry experience
- Biotechnology & Life Sciences
- Pharmaceutical
Expertise
- Project Management
- Research & Development
- Discovery